EL CENTRO, Calif. (Saturday, July 6, 2024) – Legacy MD Medical Group (formerly Vo Medical Center) is pleased to announce the acquisition and implementation of state-of-the-art Fibroscan technology for liver elastography, a medical imaging technique that maps the elastic properties and stiffness of soft tissue. Cancerous tumors are often stiffer than surrounding tissue, and diseased livers are stiffer than healthy livers. This cutting-edge equipment marks a major advancement in Legacy MD’s commitment to providing comprehensive care to patients.
FibroScan and Patients
Fibroscan is a non-invasive diagnostic tool designed to assess liver health by measuring liver stiffness and fat content in a painless procedure. Utilizing ultrasound technology, Fibroscan provides accurate, immediate results, enabling Legacy MD healthcare professionals to better evaluate liver conditions, including fibrosis and fatty liver.
FibroScan Technology System
Victor Murguia, Executive Manager at Legacy MD, expressed enthusiasm about the introduction of Fibroscan.
“We are pleased to bring this advanced technology to our hospital as it will enhance our healthcare professionals’ ability to more effectively monitor and manage liver disease. Until now, this type of accurate liver assessment has not been widely available in our hospital, and we are proud to pioneer this capability in a primary care setting,” said Murguia.
FibroScan Technology
Liver diseases such as fatty liver disease and hepatitis are becoming increasingly prevalent and often require ongoing monitoring to prevent progression to more severe conditions. Fibroscan provides fast and reliable data, enabling Legacy MD physicians to initiate timely interventions and individualized treatment plans for patients.
reference
LEGACY MD of Holtville Senior Apartment Complex
Patients can benefit from this non-invasive procedure, an alternative to more invasive methods such as liver biopsy, significantly reducing patient discomfort and recovery time.
According to www.liverfoundation.org, over 100 million people in the United States have some form of liver disease. If left untreated, liver disease can lead to liver failure and liver cancer. Chronic liver disease/cirrhosis was the 12th leading cause of death in the United States in 2020.
Additionally, www.today.com reports that “liver disease can be caused by genetics, autoimmune diseases, metabolic disorders, bile duct blockages, viruses (such as hepatitis), alcohol abuse and obesity.”
Legacy MD conducts health checks at senior apartment complexes
For more information about Fibroscan and its local availability, contact LEGACY MD – VO MEDICAL CENTER: (760) 352-2551, www.vomedicalcenter.com
